🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of entinos...
Status
Completed
Location
HOPE (Hematology Oncology Physicians & Extenders)
Start Date
2008-01-08
Trial ID
NCT00602030
Treatments Being Tested
The purpose of this randomized phase III trial is to evaluate the clinical ...
Status
Unknown
Location
Cancer Hospital Chinese Academy Medical Sciences
Start Date
2018-05-15
Trial ID
NCT03538171
Treatments Being Tested
This randomized phase III trial studies exemestane and entinostat to see ho...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-03-29
Trial ID
NCT02115282
The purpose of this study is to determine the biologically active dose of e...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research
Start Date
2016-12-19
Trial ID
NCT02915523
Treatments Being Tested
The primary objective of this study is to investigate the effect of 5 mg KH...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2017-09-22
Trial ID
NCT03291886
Treatments Being Tested
Preclinical data has demonstrated that entinostat (SNDX-275) can enhance fu...
Status
Withdrawn
Location
Tennessee Oncololgy
Start Date
2014-04
Trial ID
NCT02115594
Treatments Being Tested
The purpose of this study is to evaluate the effect of entinostat on heart ...
Status
Completed
Location
The START Center for Cancer Care
Start Date
2016-08-24
Trial ID
NCT02897778
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of entinos...
Status
Completed
Location
California Cancer Care
Start Date
2008-06-13
Trial ID
NCT00676663
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of en...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2016-05
Trial ID
NCT02708680
Treatments Being Tested